Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 3/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14577198 | 0.82 | CA1 (0.42) | CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL9936885 | 0.80 | TSHR (0.32) | — | |
| SCHEMBL29074746 | 0.78 | CA1 (0.31) | CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL1469331 | 0.77 | CHRNB2 (0.36) | CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL7737925 | 0.76 | TSHR (0.40) | — | |
| SCHEMBL11128650 | 0.75 | CHRNB2 (0.35) | CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL1128701 | 0.75 | CHRNB2 (0.37) | CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL36334 | 0.75 | ALOX15 (0.48) | CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL31685161 | 0.75 | ALOX15 (0.48) | CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL11128665 | 0.75 | CHRNB2 (0.35) | CHRNB2CHRNA4CHRNB4CHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8927759-B2 | Method for producing 2-cyanoacetic acid anhydride and further reaction products thereof | Henkel IP & Holding GmbH (DE) | 2015-01-06 | — | — | US | disclosed |
| US-20130131370-A1 | METHOD FOR PRODUCING 2-CYANOACETIC ACID ANHYDRIDE AND FURTHER REACTION PRODUCTS THEREOF | Loctite (R&D) Limited Ltd. (IE) | 2013-05-23 | — | — | US | disclosed |
| WO-2012010472-A1 | METHOD FOR PRODUCING 2-CYANOACETIC ACID ANHYDRIDE AND FURTHER REACTION PRODUCTS THEREOF | LOCTITE (R & D) LTD. (IE) | 2012-01-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130131370-A1 | METHOD FOR PRODUCING 2-CYANOACETIC ACID ANHYDRIDE AND FURTHER REACTION PRODUCTS THEREOF | PCCA, CA2, COASY | CHRNB2 1046/4885CHRNA4 1042/4885CHRNB4 1630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.